“…In the chronic infection phase, there is a slow but perceptible turnover of the viral population such that genetically distinct populations arise every few years (F Maldarelli, M Kearney, S Palmer, et al, unpubl.). In contrast, in patients on maximally suppressive therapy, evolution of viral genomes is frozen at the point at which therapy began (Ruff et al 2002;Tobin et al 2005), and no evidence for continuing evolution can be seen even after many years. In patients for which therapy is partially suppressive, ongoing evolution can still be observed (Tobin et al 2005), as is also true in patients known as "elite controllers," who naturally control HIV-1 infection at levels similar to those seen in patients on suppressive antiviral therapy (Mens et al 2010).…”